Dr Reddy's gains after FDA blow to Ranbaxy
Ranbaxy managed to recover from the day's lows after the US FDA revoked approval for its generic version of two drugs. Dr Reddy's gained after it got approval for one of its generic versions.
Other Corporate Videos
TCS screening candidates for C-suite rejig ahead; COO, CTO posts to be filled soon
Unicorn ed-tech firm Byju's lays off at least 1,000 more employees across various functions
Tata Trusts appoints Siddharth Sharma as CEO, Aparna Uppaluri as COO
Government to release standards for checking fake reviews on e-commerce, other platforms
Reliance retail, Adani group companies among bidders for Future Retail
